Progress Toward Hepatitis C Virus Elimination: Therapy and Implementation

Gastroenterol Clin North Am. 2020 Jun;49(2):253-277. doi: 10.1016/j.gtc.2020.01.005. Epub 2020 Mar 29.

Abstract

The World Health Organization has called for the elimination of hepatitis C virus (HCV) as a public health threat by 2030. Highly effective direct-acting antiviral agents provide the therapeutic tools required for elimination. In the absence of a vaccine, HCV elimination will require enhanced primary prevention and an increase in the proportions of people diagnosed and treated. Given that globally only 20% of people with chronic HCV are diagnosed, and around 5% have initiated HCV treatment, the task ahead is enormous. But, global public health needs optimism, and countries currently on track for HCV elimination provide a pathway forward.

Keywords: Direct-acting antivirals; Elimination; Global health; Hepatitis C; People who inject drugs; Sustainable development goals; Treatment; Universal health coverage.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • 2-Naphthylamine
  • Anilides / administration & dosage
  • Antiviral Agents / administration & dosage*
  • Antiviral Agents / economics
  • Benzofurans / administration & dosage
  • Carbamates / administration & dosage
  • Drug Therapy, Combination
  • Global Health
  • Health Care Costs
  • Hepatitis C, Chronic / diagnosis
  • Hepatitis C, Chronic / drug therapy*
  • Hepatitis C, Chronic / economics
  • Hepatitis C, Chronic / prevention & control*
  • Humans
  • Imidazoles / administration & dosage
  • Proline
  • Pyrrolidines
  • Sofosbuvir / administration & dosage
  • Sulfonamides / administration & dosage
  • Uracil / administration & dosage
  • Uracil / analogs & derivatives
  • Valine / analogs & derivatives
  • World Health Organization

Substances

  • Anilides
  • Antiviral Agents
  • Benzofurans
  • Carbamates
  • Imidazoles
  • Pyrrolidines
  • Sulfonamides
  • ombitasvir
  • Uracil
  • elbasvir
  • Proline
  • 2-Naphthylamine
  • dasabuvir
  • Valine
  • daclatasvir
  • Sofosbuvir